Last updated on March 2019

A Study of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis


Brief description of study

The purpose of this study is to evaluate the safety, tolerability, and efficacy of the combination of INCB050465 and ruxolitinib in subjects with myelofibrosis.

Clinical Study Identifier: NCT02718300

Find a site near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.